Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Pitts

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Therapeutic Innovation & Regulatory Science|September 21, 2018
Associate Editor's Commentary: Measuring ResponsibilityPeter J Pitts
The Patient|April 12, 2023
The Pogo-ization of Post-Pandemic Vaccine PolicyPeter J Pitts
The Journal of Medicine and Philosophy|October 9, 2008
FDA and the critical path to twenty-first-century medicinePeter J Pitts
Therapeutic Innovation & Regulatory Science|September 19, 2018
Editorial Board Member's Commentary: Commissioner Scott Gottlieb's Predictable ImaginariumPeter J Pitts
The Patient|October 18, 2021
Authors' Reply to Ibrahim and Nair's Comment on: "Health Literacy: The Common Denominator of Healthcare Progress"Peter J Pitts, Emily Freeman
The Patient|July 7, 2021
Health Literacy: The Common Denominator of Healthcare ProgressPeter J Pitts, Emily Freeman
Therapeutic Innovation & Regulatory Science|May 16, 2018
From the Valley of Death to the Crossroads of Opportunity: A Discussion of Evolving Benefit/Risk Evaluation StandardsPeter J Pitts, Patrick Brady
Therapeutic Innovation & Regulatory Science|November 5, 2020
Correction to: Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 PandemicPeter J Pitts, François Houÿez
Therapeutic Innovation & Regulatory Science|October 28, 2020
Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 PandemicPeter J Pitts, François Houÿez
Therapeutic Innovation & Regulatory Science|September 19, 2018
Implications of CRISPR-Based Germline Engineering for Cancer SurvivorsGregory Katz, Peter J Pitts
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|September 21, 2018
Associate Editor's Commentary: Measuring ResponsibilityPeter J Pitts
The Patient|April 12, 2023
The Pogo-ization of Post-Pandemic Vaccine PolicyPeter J Pitts
The Journal of Medicine and Philosophy|October 9, 2008
FDA and the critical path to twenty-first-century medicinePeter J Pitts
Therapeutic Innovation & Regulatory Science|September 19, 2018
Editorial Board Member's Commentary: Commissioner Scott Gottlieb's Predictable ImaginariumPeter J Pitts
The Patient|October 18, 2021
Authors' Reply to Ibrahim and Nair's Comment on: "Health Literacy: The Common Denominator of Healthcare Progress"Peter J Pitts, Emily Freeman
The Patient|July 7, 2021
Health Literacy: The Common Denominator of Healthcare ProgressPeter J Pitts, Emily Freeman
Therapeutic Innovation & Regulatory Science|May 16, 2018
From the Valley of Death to the Crossroads of Opportunity: A Discussion of Evolving Benefit/Risk Evaluation StandardsPeter J Pitts, Patrick Brady
Therapeutic Innovation & Regulatory Science|November 5, 2020
Correction to: Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 PandemicPeter J Pitts, François Houÿez
Therapeutic Innovation & Regulatory Science|October 28, 2020
Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 PandemicPeter J Pitts, François Houÿez
Therapeutic Innovation & Regulatory Science|September 19, 2018
Implications of CRISPR-Based Germline Engineering for Cancer SurvivorsGregory Katz, Peter J Pitts
Pageof 4